Camlin Fine Sciences Reports Mixed Financial Results Amid Record Sales in March 2025

Camlin Fine Sciences, a player in the specialty chemicals industry, has reported its financial results for the quarter ending March 2025. The company has experienced notable developments in its financial metrics, leading to an adjustment in its evaluation. The quarter showcased a significant achievement in net sales, reaching Rs 437.46 crore, marking the highest figure in the last five quarters. This upward trend in sales is indicative of a robust near-term performance. Additionally, the operating profit to interest ratio has also reached a peak of 3.69 times, reflecting an enhanced capacity to manage interest obligations. Operating profit, measured as PBDIT, stood at Rs 59.41 crore, further emphasizing the company's positive operational efficiency with an operating profit margin of 13.58%. However, not all aspects of the financial results were favorable. The profit before tax (PBT) has shown a decline of 52.22% year-on-year, while profit after tax (PAT) decreased by 16.2% year-on-year, indicating challenges in profitability despite the positive sales performance. Overall, Camlin Fine Sciences has undergone a revision in its score, reflecting the mixed outcomes of its latest financial results. Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.